senazole

Known as: sanazole, technetium-99m-cyclam AK 2123 
 

Topic mentions per year

Topic mentions per year

1998-2018
024619982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
AIM OF STUDY To explore sanazole (AK) directed targeting of the antineoplastic drug doxorubicin (DOX) complexed with silver… (More)
Is this relevant?
2013
2013
PURPOSE This study was conducted to determine the synergistic radiation sensitizing effects of the combination of sanazole and… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
2009
2009
Sanazole has been tested clinically as a hypoxic cell radiosensitizer. In this study, we determined whether sanazole enhances the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Sanazole has been tested clinically as a hypoxic cell radiosensitizer. The aim of the present study was to investigate whether… (More)
Is this relevant?
2006
2006
UNLABELLED Oropharynx is an important site of cancer in India. Global comparison indicates higher incidences in India… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
Sanazole (AK-2123, 3-nitrotriazole derivative, N1-(3-methoxypropyl)-2-(3-nitro-1 H-1,2,4-triazol-1-yl)acetamide) and nimorazole… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2004
2004
The preparation of a polyazamacrocyclic-nitrotriazole conjugate for radiolabeling with the therapeutic radioisotope viz. (177)Lu… (More)
Is this relevant?
2003
2003
Sanazole (AK-2123) (N-2'-methoxy ethyl)-2-(3"-nitro-1"-triazolyl)acetamide, which has completed phase III clinical trials as a… (More)
Is this relevant?
2001
2001
The influence of sanazole and metronidazole on cytochrome C (Cyt c(3+)) reduction in the enzyme systems xanthine/xanthine oxidase… (More)
Is this relevant?
2000
2000
The redox chemistry of sanazole, an efficient hypoxic cell radiosensitizer, generally referred to as AK-2123, was studied by… (More)
Is this relevant?